https://www.selleckchem.com/pr....oducts/17-AAG(Geldan
optimization in limiting the cardiac and substructures dose during free-breathing RT with both IMRT/VMAT for patients who are not compliant with breath-hold RT. However, this study also presents that 4D robust optimization can reduce LAD dose but not fully outperform DIBH or conventional 4D-CT-based planning with IMRT/VMAT in heart sparing in treating early staged left-sided BC patients. This study demonstrated the clinical feasibility of 4D robust optimization in limiting the cardiac and substructures dose during free-brea
Like
Comment
Share
